Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
| Autor: | Marco Tulio Souza, Antonio Carlos Carvalho, Iran Gonçalves, Adriano Henrique Pereira Barbosa, Cláudia Rodrigues Alves, Suzi Emiko Kawakami, Adriano Caixeta, P I M Moraes, Antonio Celio Camargo Moreno |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Framingham Risk Score business.industry Cardiogenic shock cardiogenic shock Ischemia Tenecteplase Coronary Artery Disease risk stratification medicine.disease reperfusion STEMI St elevation myocardial infarction Internal medicine Shock (circulatory) Cohort Risk stratification medicine Cardiology medicine.symptom Cardiology and Cardiovascular Medicine business medicine.drug thrombolytic therapy |
| Zdroj: | Open Heart |
| ISSN: | 2053-3624 |
| Popis: | ObjectiveTo validate the Intra-aortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) score in patients with cardiogenic shock after ST elevation myocardial infarction (STEMI) treated with pharmacoinvasive strategy (PhIS) and to analyse the influence of ischaemia time on different risk strata.MethodsWe analysed 2143 patients with STEMI who underwent reperfusion with tenecteplase in primary health services between May 2010 and April 2017 and were transferred to a tertiary hospital for cardiac catheterisation and continuity of care. Those who evolved to cardiogenic shock were scored as low (0–2), moderate (3–4) or high (5–9) risk of death in 30 days and pairwise-log-rank test was used to compare strata. Time intervals between symptoms onset and lytic (pain-to-needle) and fibrinolytic-catheterisation were also compared.ResultsCardiogenic shock occurred in 212 (9.9%) individuals. The 30-day mortality using the IABP-SHOCK II score was 26.6% for low-risk (n=94), 53.2% for moderate-risk (n=62) and 76% for high-risk (n=25) analysed patients (pConclusionsIn patients with cardiogenic shock after STEMI treated with PhIS, risk stratification using IABP-SHOCK II score was adequate. There was no influence of pain-to-needle and fibrinolytic-catheterisation times on the ability to the score model stratification. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|